Skip to content

Comparative Efficacy of Oily Form vs. Micellized Nano-Droplet Form Vitamin D3

Efficacy of Supplementation with Oily Form Vitamin D3 Vs. Micellized Nano-Droplet Form Vitamin D3 in Children: A Randomized Controlled Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/10/010052
Enrollment
97
Registered
2017-10-09
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Stable

Interventions

Intervention1: MIcellized Nanodroplet Form Vitamin D3: Micellized Nanodroplet Form Vitamin D3 600IU/day for 3 months Control Intervention1: Oily Form Vitamin D3: Oily Form Vitamin D3 600IU/day for 3 m

Sponsors

Aligarh Muslim University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Children in the age group of 1-10 years attending the Pediatric O.P.D. of J.N. Med. College, A.M.U. will be screened for eligibility for inclusion in the study.

Exclusion criteria

Exclusion criteria: 1)Refusal of parental consent 2)Features of nutritional rickets or serum vitamin D levels 3)History of repeated fractures 4)Chronic medical disorders e.g., chronic diarrhea, chronic liver disease, chronic renal disease 5)Vitamin D / mineral supplements ( including herbal drugs ) within 8 wks 6)Blood transfusion within 3 months 7)Malignancy 8)Obesity 9)Children on anticonvulsant medications, glucocorticoids, antifungals such as ketoconazole, and medications for AIDS

Design outcomes

Primary

MeasureTime frame
Change in serum 25(OH)D3 levels Timepoint: 90 days

Secondary

MeasureTime frame
Changes in: 1)Serum calcium levels 2)Serum phosphorus levels 3)Serum alkaline phosphatase levelsTimepoint: 90 days

Countries

India

Contacts

Public ContactMohammad Nadeem Aslam

Aligarh Muslim University

zzrab@yahoo.co.in05712721182

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026